162 related articles for article (PubMed ID: 8176213)
1. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.
Marshall KW; Liu AF; Canales J; Perahia B; Jorgensen B; Gantzos RD; Aguilar B; Devaux B; Rothbard JB
J Immunol; 1994 May; 152(10):4946-57. PubMed ID: 8176213
[TBL] [Abstract][Full Text] [Related]
2. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401.
Hill CM; Liu A; Marshall KW; Mayer J; Jorgensen B; Yuan B; Cubbon RM; Nichols EA; Wicker LS; Rothbard JB
J Immunol; 1994 Mar; 152(6):2890-8. PubMed ID: 8144889
[TBL] [Abstract][Full Text] [Related]
3. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
[TBL] [Abstract][Full Text] [Related]
4. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
Newton-Nash DK; Eckels DD
J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements of peptide and MHC for DR(alpha, beta 1*0401)-restricted T cell antigen recognition.
McNicholl JM; Whitworth WC; Oftung F; Fu X; Shinnick T; Jensen PE; Simon M; Wohlhueter RM; Karr RW
J Immunol; 1995 Aug; 155(4):1951-63. PubMed ID: 7636246
[TBL] [Abstract][Full Text] [Related]
7. Analysis of allele-specific contact sites of natural HLA-DR17 ligands.
Malcherek G; Gnau V; Stevanovic S; Rammensee HG; Jung G; Melms A
J Immunol; 1994 Aug; 153(3):1141-9. PubMed ID: 8027545
[TBL] [Abstract][Full Text] [Related]
8. Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.
Kropshofer H; Max H; Halder T; Kalbus M; Muller CA; Kalbacher H
J Immunol; 1993 Nov; 151(9):4732-42. PubMed ID: 8409432
[TBL] [Abstract][Full Text] [Related]
9. Conformational and structural characteristics of peptides binding to HLA-DR molecules.
Hill CM; Hayball JD; Allison AA; Rothbard JB
J Immunol; 1991 Jul; 147(1):189-97. PubMed ID: 1711073
[TBL] [Abstract][Full Text] [Related]
10. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
[TBL] [Abstract][Full Text] [Related]
11. The relative importance of individual DR binding motif positions as defined by peptide anchor analysis of influenza hemagglutinin peptide 306-318 and human myelin basic protein peptide 152-165 binding to several DR molecules: definition of a common extended DR binding motif.
Posch PE; Hastings AE; Rosen-Bronson S; Richert JR; Hurley CK
Eur J Immunol; 1996 Aug; 26(8):1884-91. PubMed ID: 8765035
[TBL] [Abstract][Full Text] [Related]
12. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
[TBL] [Abstract][Full Text] [Related]
13. Individual effects of the DR11-variable beta-chain residues 67, 71, and 86 upon DR(alpha,beta 1*1101)-restricted, peptide-specific T cell proliferation.
McKinney JS; Fu XT; Swearingen C; Klohe E; Karr RW
J Immunol; 1994 Dec; 153(12):5564-71. PubMed ID: 7989758
[TBL] [Abstract][Full Text] [Related]
14. On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs.
O'Sullivan D; Arrhenius T; Sidney J; Del Guercio MF; Albertson M; Wall M; Oseroff C; Southwood S; Colón SM; Gaeta FC
J Immunol; 1991 Oct; 147(8):2663-9. PubMed ID: 1717570
[TBL] [Abstract][Full Text] [Related]
15. T cell receptor and peptide-contacting residues in the HLA-DR17(3) beta 1 chain.
Geluk A; Fu XT; van Meijgaarden KE; Jansen YY; De Vries RR; Karr RW; Ottenhoff TH
Eur J Immunol; 1994 Dec; 24(12):3241-4. PubMed ID: 7805754
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of the allele specific Ag-binding site on murine class II MHC].
Kajino K
Hokkaido Igaku Zasshi; 1996 Mar; 71(2):187-203. PubMed ID: 8641675
[TBL] [Abstract][Full Text] [Related]
18. MHC class II binding of peptides derived from HLA-DR 1.
Harris PE; Liu Z; Suciu-Foca N
J Immunol; 1992 Apr; 148(7):2169-74. PubMed ID: 1545124
[TBL] [Abstract][Full Text] [Related]
19. Prediction of peptide affinity to HLA DRB1*0401.
Marshall KW; Wilson KJ; Liang J; Woods A; Zaller D; Rothbard JB
J Immunol; 1995 Jun; 154(11):5927-33. PubMed ID: 7751636
[TBL] [Abstract][Full Text] [Related]
20. The importance of DR4Dw4 beta chain residues 70, 71, and 86 in peptide binding and T cell recognition.
Signorelli KL; Watts LM; Lambert LE
Cell Immunol; 1995 May; 162(2):217-24. PubMed ID: 7743549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]